Latent Labs is a London-headquartered AI-for-biology company incorporated in mid-2023 by Dr. Simon Kohl — previously co-lead of DeepMind's protein-design team, senior research scientist on the Nobel-Prize-winning AlphaFold2, and setup lead of DeepMind's wet lab at the Francis Crick Institute. The company builds foundation models for programmable biology, shipping the Latent-X protein-design platform and Latent-Y agent that autonomously designs therapeutic antibodies from a text prompt. Latent Labs emerged from stealth in February 2025 with $50M total funding, including a $40M Series A co-led by Radical Ventures and Sofinnova Partners (with Flying Fish, Isomer, 8VC, Kindred Capital, Pillar VC, and angels including Jeff Dean, Aidan Gomez, and Mati Staniszewski). ~20 employees across London (frontier models) and San Francisco (in-house wet lab for validation), with hires from DeepMind, Microsoft, Google, Stability AI, Exscientia, Mammoth Bio, Altos Labs, and Zymergen.